Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Biotelemetry Inc (BEAT)

$41.75 0.52 (1.23%)

16:13 EDT BEAT Stock Quote Delayed 15 Minutes

Volume:

Previous Close $41.75

Market Cap 1.37B

PE Ratio -112.84

EPS -0.37

Volume (Avg. Vol.) 253,500

Day's Range 40.81 - 42.87

52-Week Range 38.45 - 80.92

Dividend & Yield N/A (N/A)

BEAT Stock Predictions, Articles, and Biotelemetry Inc News

From InvestorPlace
From the Web

10 Triple-A Stocks to Buy for the Rest of 2018

By Louis Navellier, Editor, Growth Investor Nov 21, 2018

Here are some triple-a stocks to buy that are primed to start the new year going strong.

7 Market-Beating Stocks to Buy to Weather a Trade War

By Louis Navellier, Editor, Growth Investor Sep 21, 2018

As potential impacts from the trade war with China loom, these stocks to buy are far more prepared to weather the storm.

4 Top Stocks to Buy on Blockbuster Earnings Growth

By Zacks Investment Research Jul 31, 2018

We shortlist four solid stocks that have striking earnings growth and positive estimate revisions. Compare Brokers....

10 Small-Caps Leading the Market Rebound

By Anthony Mirhaydari, InvestorPlace Market Strategist Jul 10, 2018

The tone of trade is a definitive "risk on" with equities rallying, Treasury bonds pulling back and overall market breadth strong. The action in small-cap stocks has been particularly impressive, with the Russell 2000 set to cap a five-day winning streak.

3 Heart Disease Focused Stocks to Buy Ahead of World Heart Day

By Zacks Investment Research Sep 27, 2017

With World Heart Day coming up, here is a look at some well-positioned stocks including BioTelemetry (BEAT) in this segment of the market.

Is BioTelemetry, Inc. (NASDAQ:BEAT) Investing Effectively In Its Business?

From Simply Wall St Sep 17, 2019

Today we are going to look at BioTelemetry, Inc. (NASDAQ:BEAT) to see whether it might be an attractive investment prospect. To be precise, we’ll consider its Return On Capital Employed<div><a class="permalink" href="https://simplywall.st/stocks/us/healthcare/nasdaq-beat/biotelemetry/news/is-biotelemetry-inc-nasdaqbeat-investing-effectively-in-its-business-2/">Read More...</a></div>

Noteworthy Tuesday Option Activity: BSX, BEAT, IMMU

From Market News Video Sep 10, 2019

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Boston Scientific Corp. (BSX), where a total of 20,580 contracts have traded so far, representing approximately 2.1 million underlying shares..

The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission

From Benzinga Aug 16, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 15) Novocure Ltd (NASDAQ:...

BioTelemetry is Now Oversold (BEAT)

From Market News Video Aug 2, 2019

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Stocks That Set New 52-Week Lows Friday Morning

From Benzinga Aug 2, 2019

Friday morning, 349 companies reached new 52-week lows. Significant Points: China Construction Bank (OTC: CICHY) was the largest firm on a market cap basis to set a...

Benzinga's Top Upgrades, Downgrades For August 2, 2019

From Benzinga Aug 2, 2019

Upgrades For Antero Resources Corp (NYSE: AR), Macquarie upgraded the previous rating of Underperform to the current rating Neutral. In the second quarter, Antero Resources...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

D

Sell

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!